ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Medical Science Liaison, Spain at Revolution Medicines - ApplyBlast

Medical Science Liaison, Spain

Revolution Medicines

3 months ago

3.5 on Glassdoor

Madrid, Community of Madrid, Spain

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Revolution Medicines is seeking a Medical Science Liaison based in Spain to serve as a scientific expert and thought partner for internal teams and healthcare professionals. The role involves engaging in peer-to-peer scientific dialogue with KOLs and HCPs, supporting medical education and congresses, and collaborating cross-functionally to advance the company's oncology portfolio. This position requires a doctoral degree and extensive experience in the pharmaceutical industry within the Spanish market.

Responsibilities

Engage in peer-to-peer scientific dialogue with healthcare professionals
Cultivate and strengthen professional relationships with key opinion leaders
Support medical education advisory boards and medical congresses

Skills

Qualifications

Doctoral degree in scientific or medical discipline

About Revolution Medicines

revmed.com

Headquarters

Redwood City, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.